ArticleVaccine2021

Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon.

Rima Moghnieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.